Management of Cardiovascular Risk Factors

AstraZeneca

Status: Completed

Conditions: Cardiovascular Diseases; Cardiovascular Risk Factors

Study type: Observational

Funder types: Industry

Identifiers

NCT00848380

NIS-CCH-DUM-2008/2

Details and patient eligibility

About

This practical experience should report a retrospective collection of data regarding cardiovascular risk factors of cardiovascular diseases. The goal is an evaluation of the development of the risk profile of cardiovascular patients with simultaneous treatment of hypertension and hyperlipidemia

Enrollment: 1,492 patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Patients received a anti-hypertension treatment in addition to cholesterol lowering treatment during the observation period
• Patients received a cholesterol lowering treatment in addition to hypertension treatment during the observation period
• Patients received during the observation time new cholesterol lowering and hypertension treatment

Exclusion criteria

• Patients received during the observation time only cholesterol lowering or only anti-hypertension treatment

Trial design

1,492 participants in 1 patient group

1

Description:

Patients with hypertension and hyperlipidemia and other CV risk factors